John C. Reed
At a glance: John C. Reed is Evp, Innovative Medicine, R&D at Johnson & Johnson (JNJ). Their latest SEC Form 4, filed Feb 18, 2026, reported a sale of $5.3M. On file: 0 purchase lines ($0) and 4 sale lines ($17.3M).
Disclosed holdings: about $2.8M of JNJ stock: 10,658 shares reported on their latest Form 4 (filed Feb 18, 2026), valued at the Nov 19, 2026 close of $267.11. This counts only JNJ shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Innovative Medicine, R&D at Johnson & Johnson (JNJ)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
John C. Reed's InsiderPrint
4 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 4 times a year, typically $5.3M a trade.
- Bump outward: a purchase (0)
- Dent inward: a sale (4)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- David A. ZapicoCEO · AME · 100% match
- Jennifer ZacharyGeneral Counsel · MRK · 100% match
- Ryan HickeCEO · SEIC · 100% match
- Douglas C. Yearley Jr.CEO · TOL · 100% match
- Rochester Regional Joint Board Fund For The Future10% Owner · AMAL · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 18SEC | JNJJohnson & Johnson | Sell | 21,72112,941 held (−63%) | $243.00 | $5.3M | +9.9% |
| Feb 18SEC | JNJJohnson & Johnson | Sell | 29,92712,941 held (−70%) | $243.00 | $7.3M | +9.9% |
| Feb 18SEC | JNJJohnson & Johnson | Sell | 2,28310,658 held (−18%) | $243.00 | $555K | +9.9% |
| Oct 20SEC | JNJJohnson & Johnson | Sell | 21,72110,658 held (−67%) | $192.71 | $4.2M | +38.6% |
- Sell
Evp, Innovative Medicine, R&D John C Reed sold $5.3M of JNJ at $243.00 — cuts the stake by 63%.
- Sell
Evp, Innovative Medicine, R&D John C Reed sold $7.3M of JNJ at $243.00 — cuts the stake by 70%.
- Sell
Evp, Innovative Medicine, R&D John C Reed sold $4.2M of JNJ at $192.71 — cuts the stake by 67%.
Follow John C. Reed
Get one email when John C. Reed files a new purchase or sale. Free.
At most one email a day about John C. Reed, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.